DoomPosting
7.76K subscribers
77.5K photos
22.6K videos
6 files
72.5K links
Degens Deteriorating
Download Telegram
JUST IN - Trump sues JPMorgan Chase and its CEO Jamie Dimon in a $5 billion lawsuit for debanking him for political reasons

๐Ÿ„ณ๐Ÿ„พ๐Ÿ„พ๐Ÿ„ผ๐Ÿ„ฟ๐Ÿค–๐Ÿ…‚๐Ÿ…ƒ๐Ÿ„ธ๐Ÿ„ฝ๐Ÿ„ถ
โคโ€๐Ÿ”ฅ11๐Ÿ˜7๐Ÿ”ฅ5๐Ÿ’ฏ3โšก1
BREAKING: United States has officially exited the World Health Organization

๐Ÿ„ณ๐Ÿ„พ๐Ÿ„พ๐Ÿ„ผ๐Ÿ„ฟ๐Ÿค–๐Ÿ…‚๐Ÿ…ƒ๐Ÿ„ธ๐Ÿ„ฝ๐Ÿ„ถ
๐Ÿ‘14๐ŸŽ‰5
This media is not supported in your browser
VIEW IN TELEGRAM
COMMANDER BOVINO WENT OFF on the fake news โ€œpressโ€ for demanding to know how many illegals have to be deported before DHS leaves MN

โ€œThe number is ALL OF THEM!โ€

โ€œYou're worried about numbers. I'm worried about the DEATHS OF AMERICANS.

Let's talk about that. Maybe Jocelyn Nungarayโ€”what her last moments were likeโ€ฆ We NEVER hear about her or the other thousands of American citizens.

I'm worried about thatโ€”VASTLY more than a number or date. We're going to make mom and pop America SAFE!โ€

๐Ÿ„ณ๐Ÿ„พ๐Ÿ„พ๐Ÿ„ผ๐Ÿ„ฟ๐Ÿค–๐Ÿ…‚๐Ÿ…ƒ๐Ÿ„ธ๐Ÿ„ฝ๐Ÿ„ถ
๐Ÿซก11โคโ€๐Ÿ”ฅ2๐Ÿ”ฅ1
No Tariffs = Bitcoin dumps

Tariffs announced = Bitcoin dumps

Tariffs cancelled = Bitcoin dumps

This market is totally broken

๐Ÿ„ณ๐Ÿ„พ๐Ÿ„พ๐Ÿ„ผ๐Ÿ„ฟ๐Ÿค–๐Ÿ…‚๐Ÿ…ƒ๐Ÿ„ธ๐Ÿ„ฝ๐Ÿ„ถ
๐Ÿ˜4๐Ÿ’ฏ3๐Ÿ‘2๐Ÿ˜ญ1
๐Ÿ”ฅ2๐Ÿ˜1๐Ÿ˜จ1
JUST IN - Trump says The Times Siena Poll will be added to his lawsuit against The New York Times

๐Ÿ„ณ๐Ÿ„พ๐Ÿ„พ๐Ÿ„ผ๐Ÿ„ฟ๐Ÿค–๐Ÿ…‚๐Ÿ…ƒ๐Ÿ„ธ๐Ÿ„ฝ๐Ÿ„ถ
๐Ÿ”ฅ7
BREAKING - Trump says he is suing New York Times:

'They have to pay a price for fake and fraudulent news"

๐Ÿ„ณ๐Ÿ„พ๐Ÿ„พ๐Ÿ„ผ๐Ÿ„ฟ๐Ÿค–๐Ÿ…‚๐Ÿ…ƒ๐Ÿ„ธ๐Ÿ„ฝ๐Ÿ„ถ
๐Ÿ”ฅ8๐Ÿ™3๐Ÿ‘1
โ€œYes, Derek, thereโ€™s only one man who can restore order in Minneapolis. We need to deprive these protesters of oxygen. But this oneโ€™s strictly off the booksโ€ฆโ€

๐Ÿ„ณ๐Ÿ„พ๐Ÿ„พ๐Ÿ„ผ๐Ÿ„ฟ๐Ÿค–๐Ÿ…‚๐Ÿ…ƒ๐Ÿ„ธ๐Ÿ„ฝ๐Ÿ„ถ
๐Ÿ˜4
๐Ÿ”ฅ4โคโ€๐Ÿ”ฅ1
AI-assisted amateurs are now cracking famous unsolved Erdล‘s problemsโ€”mathematics is changing.

Amateur mathematicians, aided by powerful AI chatbots, are starting to solve decades-old mathematical puzzles that have long challenged professionals, signaling a potential transformation in how mathematics is practiced.

A major focus has been the famous collection of over 1,000 problems posed by the legendary Hungarian mathematician Paul Erdล‘sโ€”questions known for being simple to state yet notoriously difficult to resolve. These problems, meticulously cataloged online by mathematician Thomas Bloom, have recently been fed into advanced AI tools like ChatGPT.

Modern AI systems can now not only scour vast mathematical literature for relevant theorems and results but also propose intricate proofs. For instance, undergraduate student Kevin Barreto and amateur mathematician Liam Price harnessed ChatGPT-5.2 Pro to tackle Erdล‘s problem 728 in number theory. They then verified the AI-generated proof using another system, Aristotle, which translates mathematical arguments into formal language that computers can rigorously check.

To date, AI-assisted efforts have produced solutions to six Erdล‘s problems. Upon closer inspection, five of these turned out to have been previously solved but overlooked in the literature. This leaves problem 205 as the first genuinely new solution credited to a humanโ€“AI collaboration.

Even when rediscovering existing results, experts like Thomas Bloom and Fields Medalist Terence Tao emphasize that AI is revolutionizing the process. It rapidly uncovers obscure papers, bridges gaps between mathematical subfields, and allows researchers to explore techniques far outside their personal expertise.

The problems solved so far are generally at the level a capable early PhD student might handle. The most challenging Erdล‘s questionsโ€”and those carrying substantial monetary bountiesโ€”still remain beyond current AI capabilities. Nevertheless, many mathematicians see promising โ€œgreen shootsโ€ of a new era: a more empirical, accelerated style of mathematics where AI enables the rapid, parallel exploration of thousands of problems and methods, dramatically expanding the pace and reach of discovery.

๐Ÿ„ณ๐Ÿ„พ๐Ÿ„พ๐Ÿ„ผ๐Ÿ„ฟ๐Ÿค–๐Ÿ…‚๐Ÿ…ƒ๐Ÿ„ธ๐Ÿ„ฝ๐Ÿ„ถ
๐Ÿ”ฅ3
Investor risk appetite is near-record levels:

The S&P Global Investment Manager Index rose to +41% in January, the highest reading since April 2021.

This gauge covers a monthly survey of ~300 institutional investors overseeing over $3.5 trillion in assets.

This marks the 4th consecutive monthly increase in risk appetite.

Now, 58% of fund managers expect US equity gains over the next 30 days, while only 16% anticipate losses.

As a result, the near-term market outlook jumped to +32%, the 2nd-highest in 4 years.

Wall Street is betting on a continued stock market rally.

๐Ÿ„ณ๐Ÿ„พ๐Ÿ„พ๐Ÿ„ผ๐Ÿ„ฟ๐Ÿค–๐Ÿ…‚๐Ÿ…ƒ๐Ÿ„ธ๐Ÿ„ฝ๐Ÿ„ถ
Natural molecule CaAKG restores early memory in Alzheimerโ€™s modelsโ€”aging brain hope?

Researchers at the National University of Singapore have discovered that calcium alpha-ketoglutarate (CaAKG)โ€”a naturally occurring metabolite already present in the human bodyโ€”shows remarkable potential to safeguard the aging brain against Alzheimerโ€™s disease.

In laboratory models of Alzheimerโ€™s, CaAKG significantly improved communication between neurons and revived early-stage memory processes that typically deteriorate with age. It enhanced synaptic plasticity, the brainโ€™s essential ability to form and strengthen new connections, which is vital for learning and long-term memory and is severely impaired in Alzheimerโ€™s.

The compound also boosted the brainโ€™s natural autophagy process, helping cells clear out harmful, damaged proteins that accumulate and damage neurons over time.

Importantly, the researchers identified a novel pathway through which CaAKG works: it activates specific calcium channels and receptors to increase neuronal flexibility, while avoiding disruption of other pathways often affected in Alzheimerโ€™s. The molecule successfully restored synaptic tagging and captureโ€”a critical mechanism that allows the brain to link events and form associative memories, one of the earliest cognitive functions lost in Alzheimerโ€™s disease.

Since alpha-ketoglutarate levels naturally decline with age and CaAKG is already a safe, endogenous compound, the team believes it or similar โ€œlongevityโ€ molecules could one day complement current Alzheimerโ€™s therapies. Rather than merely managing symptoms, these compounds may target the underlying biology of aging itself.

While the results are highly encouraging, they come from experimental models. Human clinical trials will be essential to confirm whether CaAKG can safely and effectively slow cognitive decline in people.

๐Ÿ„ณ๐Ÿ„พ๐Ÿ„พ๐Ÿ„ผ๐Ÿ„ฟ๐Ÿค–๐Ÿ…‚๐Ÿ…ƒ๐Ÿ„ธ๐Ÿ„ฝ๐Ÿ„ถ
๐Ÿ™3